SHANE WILLIAMON: Open Payments
NPI 1881920353 · ANNISTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,595 in 119 payments from 15 companies in 2025. Trend: 2023 $1,304 · 2024 $1,501 · 2025 $2,595
Food & beverage: $2,496Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 32 | $839 |
| GlaxoSmithKline, LLC. | 29 | $498 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $206 |
| JAZZ PHARMACEUTICALS INC. | 7 | $172 |
| Verona Pharma, Inc. | 8 | $159 |
| Regeneron Healthcare Solutions, Inc. | 9 | $139 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| GENZYME CORPORATION | 4 | $97 |
| HARMONY BIOSCIENCES LLC | 4 | $85 |
| Grifols USA, LLC | 4 | $76 |
Products named: AIRSUPRA, DUPIXENT, TRELEGY ELLIPTA, GLASSIA, FASENRA, XYWAV, NUCALA, Ohtuvayre.
Industry payments across AL — which companies pay providers there.
